Filing Flows › Cryo Cell International (CCEL) › Q2 FY25
Cryo Cell International (CCEL) Q2 FY25 earnings results (second quarter fiscal 2025)
10-Q filed Jul 15, 2025
Cryo Cell International (CCEL) reported revenue of $7.9M for the second quarter fiscal 2025 (Q2 FY25), -1% from a year earlier and -0.5% from the quarter before. Operating margin was 18.8%, net earnings $356K (4.5% of revenue).
Cryo Cell International, Q2 FY25: revenue $7.9M (-1% year over year), operating margin 18.8%, net earnings $356K, operating cash flow $707K. The chart follows the revenue to costs, profit and cash.
| Q2 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.9M | -0.5% | -1% |
| Operating profit | $1.5M | +41% | +7% |
| Net earnings | $356K | +26% | -46% |
| Operating cash flow | $707K | -26% | -60% |
| Free cash flow | $645K | -28% | 30× |
What changed
Revenue was $7.9M in Q2 FY25, down 1% year over year and down 1% from the previous quarter. Processing and Storage Fees was the largest line at 99% of revenue. Processing and Storage Fees lost $94K year over year (down 1%), 82% of the total change.
Operating profit was $1.5M, a 18.8% margin (up 1.5 points year over year). Total costs fell 3% while revenue fell 1%. Net earnings were $356K, down 46% year over year. The effective tax rate was 38.1%.
Operating cash flow was $707K (down 60% year over year), 199% of net earnings. Non-cash charges added back $250K of depreciation and amortization and $40K of share-based compensation. Working capital and other items added $61K. Capital expenditures of $62K left free cash flow of $645K.
Questions
What was Cryo Cell International's revenue in the second quarter fiscal 2025?
Cryo Cell International (CCEL) reported revenue of $7.9M for the second quarter fiscal 2025 (Q2 FY25), -1% from a year earlier and -0.5% from the quarter before.
Was Cryo Cell International profitable in the second quarter fiscal 2025?
Operating profit was $1.5M (18.8% of revenue) and net earnings $356K.